I don’t know. What you see as deep and diverse,
Post# of 148294
The problem as I see it, is that uncertainty usually is the worst ingredient for a stock. And all this group has done is introduce a lot of uncertainty as to what their intentions are. I would love to see them come out with a statement that says they will be patient to see how the ongoing trials in Brazil and the clinical process in India plays out – – and to the extent those bear no fruit, they will bring some type of cohesive message.
And if we get nothing from PI, Brazil, or India - I’ll be open to other options. But for now, it’s noise -
and downward pressure on our valuation.